Cargando…

Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer

Accurate identification of molecular targets of disease plays an important role in diagnosis, prognosis, and therapies. Breast cancer (BC) is one of the most common malignant cancers in women worldwide. Thus, the objective of this study was to accurately identify a set of molecular targets and small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alam, Md Shahin, Sultana, Adiba, Sun, Hongyang, Wu, Jin, Guo, Fanfan, Li, Qing, Ren, Haigang, Hao, Zongbing, Zhang, Yi, Wang, Guanghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531711/ https://www.ncbi.nlm.nih.gov/pubmed/36204232 http://dx.doi.org/10.3389/fphar.2022.942126

Ejemplares similares

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer
por: Alam, Md Shahin, et al.
Publicado: (2022)

Regulation of Pain Genes—Capsaicin vs Resiniferatoxin: Reassessment of Transcriptomic Data
por: Singla, Rajeev K., et al.
Publicado: (2020)

Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies
por: Alam, Md. Shahin, et al.
Publicado: (2022)

Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches
por: Sultana, Adiba, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Discovery of novel immunotherapeutic drug candidates for sciatic nerve injury using bioinformatic analysis and experimental verification
por: Li, Shengyou, et al.
Publicado: (2022)

Organelle Interaction and Drug Discovery: Towards Correlative Nanoscopy and Molecular Dynamics Simulation
por: Yang, Zhiwei, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Integrated bioinformatics analysis uncovers characteristic genes and molecular subtyping system for endometriosis
por: Wang, Zhaowei, et al.
Publicado: (2022)

Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products
por: Du, Yue, et al.
Publicado: (2022)

Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR
por: Hao, Zongbing, et al.
Publicado: (2019)

Integrated Network Pharmacology and Comprehensive Bioinformatics Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula for Treatment of Comorbidity With Alzheimer’s Disease and Depression
por: Zhang, Tingting, et al.
Publicado: (2022)

Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled?
por: Roth, Bryan L.
Publicado: (2006)

Inhibition of the PINK1-Parkin Pathway Enhances the Lethality of Sorafenib and Regorafenib in Hepatocellular Carcinoma
por: Zhang, Shun, et al.
Publicado: (2022)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
por: Liu, Jiawei, et al.
Publicado: (2022)

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation
por: Tian, Xiaoyan, et al.
Publicado: (2022)

Exploring the mechanism of action of licorice in the treatment of COVID-19 through bioinformatics analysis and molecular dynamics simulation
por: Cao, Jun-Feng, et al.
Publicado: (2022)

Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs
por: Lipinski, Christopher A., et al.
Publicado: (2022)

Anoikis-related long non-coding RNA signatures to predict prognosis and small molecular drug response in cervical cancer
por: Liang, Hao, et al.
Publicado: (2023)

Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson’s Disease
por: Wang, Rui, et al.
Publicado: (2020)

Systems Pharmacology in Small Molecular Drug Discovery
por: Zhou, Wei, et al.
Publicado: (2016)

Molecular Modeling Applied to the Discovery of New Lead Compounds for P2 Receptors Based on Natural Sources
por: Alberto, Anael Viana Pinto, et al.
Publicado: (2020)

Bioinformatics Research on Drug Sensitivity Prediction
por: Chen, Yaojia, et al.
Publicado: (2021)

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations
por: Almeleebia, Tahani M., et al.
Publicado: (2022)

In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis
por: Ge, Chenliang, et al.
Publicado: (2020)

An Integrated Deep Learning and Molecular Dynamics Simulation-Based Screening Pipeline Identifies Inhibitors of a New Cancer Drug Target TIPE2
por: Zhang, Haiping, et al.
Publicado: (2021)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022)

Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents
por: Horaira, Md Abu, et al.
Publicado: (2023)

The Molecular Determinants of Small-Molecule Ligand Binding at P2X Receptors
por: Pasqualetto, Gaia, et al.
Publicado: (2018)

Discovery of potent STAT3 inhibitors using structure-based virtual screening, molecular dynamic simulation, and biological evaluation
por: Liu, Weifeng, et al.
Publicado: (2023)

Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach
por: Akash, Shopnil, et al.
Publicado: (2023)

Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study
por: Bhowmik, Ratul, et al.
Publicado: (2023)

Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis
por: Qiu, Hui-Zhu, et al.
Publicado: (2020)

Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment
por: Zhou, Jiao, et al.
Publicado: (2023)

Label-free drug discovery
por: Fang, Ye
Publicado: (2014)

Editorial: Molecular imaging for tracking drug delivery
por: Han, Zheng, et al.
Publicado: (2023)

Bioinformatics and Drug Discovery
por: Xia, Xuhua
Publicado: (2017)

Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview
por: Li, Liu-Ying, et al.
Publicado: (2022)

Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms
por: Ramprasath, Tharmarajan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ugpom2n5qhqdr8ocgs4kknfg7